JOMMI, CLAUDIO
JOMMI, CLAUDIO
Accordi di managed market entry (risk-sharing): razionale e tendenze evolutive nel SSN
2012 Jommi, Claudio
An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration
2022 Finch, Aureliano Paolo; Meregaglia, Michela; Ciani, Oriana; Roudijk, Bram; Jommi, Claudio
An introduction to economic evaluation of health care programs
2017 Jommi, Claudio
Analisi di impatto sul budget di WatchmanTM, dispositivo per la prevenzione tromboembolica nei pazienti con fibrillazione atriale
2013 Jommi, Claudio; A., Iorio; L., Crippa; A., Gelera; G., Senatore
Biosimilari
2010 Jommi, Claudio
Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives
2018 Rognoni, Carla; Bertolani, Arianna; Jommi, Claudio
CAR T-cell therapies in Italy: patient access barriers and recommendations for health system solutions
2022 Jommi, Claudio; Bramanti, Stefania; Pani, Marcello; Ghirardini, Alessandro; Santoro, Armando
Clinical management of chronic Kidney disease patients in Italy: results from the IRIDE study
2018 Cozzolino, Mario; Bolasco, Piergiorgio; Ronco, Claudio; Conte, Giuseppe; Menè, Paolo; Cristina Mereu, Maria; Di Luca, Marina; Roccatello, Dario; Rosati, Alberto; Jommi, Claudio; Maria Costanzo, Anna; Gualberti, Giuliana; di Luzio Paparatti, Umberto; Remuzzi, Giuseppe
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
2024 Cavallo, Maria Caterina; Cavazza, Marianna; Bonifazi, Francesca; Casadei, Beatrice; Cutini, Ilaria; Tonietti, Barbara; Saccardi, Riccardo; Zinzani, Pierluigi; Jommi, Claudio
Cost-effectiveness and net monetary benefit of durvalumab consolidation therapy versus no consolidation therapy after chemoradiotherapy in stage III non–small cell lung cancer in the Italian National Health Service
2020 Armeni, Patrizio; Borsoi, Ludovica; Fornaro, Giulia; Jommi, Claudio; Grossi, Francesco; Costa, Francesco
Cost-effectiveness and net monetary benefit of Olaparib maintenance therapy versus no maintenance therapy after first-line platinum-based chemotherapy in newly diagnosed advanced BRCA1/2-mutated ovarian cancer in the Italian National Health Service
2020 Armeni, Patrizio; Borsoi, Ludovica; Fornaro, Giulia; Jommi, Claudio; Colombo, Nicoletta; Costa, Francesco
Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system
2021 Riva, Silvia; Arenare, Laura; Di Maio, Massimo; Efficace, Fabio; Montesarchio, Vincenzo; Frontini, Luciano; Giannarelli, Diana; Bryce, Jane; Del Campo, Laura; De Lorenzo, Francesco; Iannelli, Elisabetta; Traclò, Francesca; Gitto, Lara; Jommi, Claudio; Vaccaro, Concetta Maria; Barberio, Daniela; Cinieri, Saverio; Porta, Camillo; Del Mastro, Lucia; Zagonel, Vittorina; Aligi Cogoni, Alessio; Bordonaro, Roberto; Gimigliano, Anna; Piccirillo, Maria Carmela; Guizzaro, Lorenzo; Gallo, Ciro; Perrone, Francesco
Current pipelines for neglected diseases
2014 P., Procolo; Jommi, Claudio
De innovatione: the concept of innovation for medical technologies and its implications for healthcare policy-making
2016 Ciani, Oriana; Armeni, Patrizio; Boscolo, PAOLA ROBERTA; Cavazza, Marianna; Jommi, Claudio; Tarricone, Rosanna
Determinants of price negotiations for new drugs. The experience of the Italian Medicines Agency
2019 Villa, Federico; Tutone, Michaela; Altamura, Gianluca; Antignani, Sara; Cangini, Agnese; Fortino, Ida; Melazzini, Mario; Trotta, Francesco; Tafuri, Giovanni; Jommi, Claudio
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol
2019 Riva, Silvia; Bryce, Jane; De Lorenzo, Francesco; Del Campo, Laura; Di Maio, Massimo; Efficace, Fabio; Frontini, Luciano; Giannarelli, Diana; Gitto, Lara; Iannelli, Elisabetta; Jommi, Claudio; Montesarchio, Vincenzo; Traclò, Francesca; Vaccaro, Concetta Maria; Gallo, Ciro; Perrone, Francesco
Diagnostic accuracy of HLA-B*5701 screening for the prediction of abacavir hypersensitivity and clinical utility of the test: a meta-analytic review
2014 S., Cargnin; Jommi, Claudio; Canonico, P. L.
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case
2023 Tarantola, Alice; Otto, Monica Hildegard; Armeni, Patrizio; Costa, Francesco; Malandrini, Francesco; Jommi, Claudio
Education and research on drug market access in low-income countries: the experience of the Department of Pharmaceutical Sciences in Novara
2013 Jommi, Claudio; P., di Procolo; V., Drago
EQ-5D-5L population norms for Italy
2023 Meregaglia, Michela; Malandrini, Francesco; Finch, Aureliano Paolo; Ciani, Oriana; Jommi, Claudio
| Titolo | Data di pubblicazione | Autore(i) | Rivista | Editore |
|---|---|---|---|---|
| Accordi di managed market entry (risk-sharing): razionale e tendenze evolutive nel SSN | 1-gen-2012 | Jommi, Claudio | PHARMACOECONOMICS, ITALIAN RESEARCH ARTICLES | - |
| An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration | 1-gen-2022 | Finch, Aureliano Paolo; Meregaglia, Michela; Ciani, Oriana; Roudijk, Bram; Jommi, Claudio | SOCIAL SCIENCE & MEDICINE | - |
| An introduction to economic evaluation of health care programs | 1-gen-2017 | Jommi, Claudio | - | Academic Press |
| Analisi di impatto sul budget di WatchmanTM, dispositivo per la prevenzione tromboembolica nei pazienti con fibrillazione atriale | 1-gen-2013 | Jommi, Claudio; A., Iorio; L., Crippa; A., Gelera; G., Senatore | PHARMACOECONOMICS, ITALIAN RESEARCH ARTICLES | - |
| Biosimilari | 1-gen-2010 | Jommi, Claudio | PHARMACOECONOMICS, ITALIAN RESEARCH ARTICLES | - |
| Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives | 1-gen-2018 | Rognoni, Carla; Bertolani, Arianna; Jommi, Claudio | GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT | - |
| CAR T-cell therapies in Italy: patient access barriers and recommendations for health system solutions | 1-gen-2022 | Jommi, Claudio; Bramanti, Stefania; Pani, Marcello; Ghirardini, Alessandro; Santoro, Armando | FRONTIERS IN PHARMACOLOGY | - |
| Clinical management of chronic Kidney disease patients in Italy: results from the IRIDE study | 1-gen-2018 | Cozzolino, Mario; Bolasco, Piergiorgio; Ronco, Claudio; Conte, Giuseppe; Menè, Paolo; Cristina Mereu, Maria; Di Luca, Marina; Roccatello, Dario; Rosati, Alberto; Jommi, Claudio; Maria Costanzo, Anna; Gualberti, Giuliana; di Luzio Paparatti, Umberto; Remuzzi, Giuseppe | NEPHRON JOURNALS | - |
| Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study | 1-gen-2024 | Cavallo, Maria Caterina; Cavazza, Marianna; Bonifazi, Francesca; Casadei, Beatrice; Cutini, Ilaria; Tonietti, Barbara; Saccardi, Riccardo; Zinzani, Pierluigi; Jommi, Claudio | BMC HEALTH SERVICES RESEARCH | - |
| Cost-effectiveness and net monetary benefit of durvalumab consolidation therapy versus no consolidation therapy after chemoradiotherapy in stage III non–small cell lung cancer in the Italian National Health Service | 1-gen-2020 | Armeni, Patrizio; Borsoi, Ludovica; Fornaro, Giulia; Jommi, Claudio; Grossi, Francesco; Costa, Francesco | CLINICAL THERAPEUTICS | - |
| Cost-effectiveness and net monetary benefit of Olaparib maintenance therapy versus no maintenance therapy after first-line platinum-based chemotherapy in newly diagnosed advanced BRCA1/2-mutated ovarian cancer in the Italian National Health Service | 1-gen-2020 | Armeni, Patrizio; Borsoi, Ludovica; Fornaro, Giulia; Jommi, Claudio; Colombo, Nicoletta; Costa, Francesco | CLINICAL THERAPEUTICS | - |
| Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system | 1-gen-2021 | Riva, Silvia; Arenare, Laura; Di Maio, Massimo; Efficace, Fabio; Montesarchio, Vincenzo; Frontini, Luciano; Giannarelli, Diana; Bryce, Jane; Del Campo, Laura; De Lorenzo, Francesco; Iannelli, Elisabetta; Traclò, Francesca; Gitto, Lara; Jommi, Claudio; Vaccaro, Concetta Maria; Barberio, Daniela; Cinieri, Saverio; Porta, Camillo; Del Mastro, Lucia; Zagonel, Vittorina; Aligi Cogoni, Alessio; Bordonaro, Roberto; Gimigliano, Anna; Piccirillo, Maria Carmela; Guizzaro, Lorenzo; Gallo, Ciro; Perrone, Francesco | BMJ OPEN | - |
| Current pipelines for neglected diseases | 1-gen-2014 | P., Procolo; Jommi, Claudio | PLOS ONE | - |
| De innovatione: the concept of innovation for medical technologies and its implications for healthcare policy-making | 1-gen-2016 | Ciani, Oriana; Armeni, Patrizio; Boscolo, PAOLA ROBERTA; Cavazza, Marianna; Jommi, Claudio; Tarricone, Rosanna | HEALTH POLICY AND TECHNOLOGY | - |
| Determinants of price negotiations for new drugs. The experience of the Italian Medicines Agency | 1-gen-2019 | Villa, Federico; Tutone, Michaela; Altamura, Gianluca; Antignani, Sara; Cangini, Agnese; Fortino, Ida; Melazzini, Mario; Trotta, Francesco; Tafuri, Giovanni; Jommi, Claudio | HEALTH POLICY | - |
| Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol | 1-gen-2019 | Riva, Silvia; Bryce, Jane; De Lorenzo, Francesco; Del Campo, Laura; Di Maio, Massimo; Efficace, Fabio; Frontini, Luciano; Giannarelli, Diana; Gitto, Lara; Iannelli, Elisabetta; Jommi, Claudio; Montesarchio, Vincenzo; Traclò, Francesca; Vaccaro, Concetta Maria; Gallo, Ciro; Perrone, Francesco | BMJ OPEN | - |
| Diagnostic accuracy of HLA-B*5701 screening for the prediction of abacavir hypersensitivity and clinical utility of the test: a meta-analytic review | 1-gen-2014 | S., Cargnin; Jommi, Claudio; Canonico, P. L. | PHARMACOGENOMICS | - |
| Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case | 1-gen-2023 | Tarantola, Alice; Otto, Monica Hildegard; Armeni, Patrizio; Costa, Francesco; Malandrini, Francesco; Jommi, Claudio | JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE | - |
| Education and research on drug market access in low-income countries: the experience of the Department of Pharmaceutical Sciences in Novara | 1-gen-2013 | Jommi, Claudio; P., di Procolo; V., Drago | - | EGEA |
| EQ-5D-5L population norms for Italy | 1-gen-2023 | Meregaglia, Michela; Malandrini, Francesco; Finch, Aureliano Paolo; Ciani, Oriana; Jommi, Claudio | APPLIED HEALTH ECONOMICS AND HEALTH POLICY | - |